Liquidity (Details Narrative) - USD ($) |
3 Months Ended | 6 Months Ended | 9 Months Ended | |||
---|---|---|---|---|---|---|
Aug. 31, 2016 |
Dec. 31, 2015 |
Jun. 30, 2016 |
Sep. 30, 2016 |
Sep. 30, 2015 |
Dec. 31, 2014 |
|
Accumulated deficit | $ 13,277,814 | $ 25,706,214 | ||||
Gross proceeds from sale of stock | 15,235,283 | $ 10,819,714 | ||||
Cash and cash equivalents | 12,338,275 | 18,909,348 | $ 13,172,926 | $ 6,262,445 | ||
Cystic Fibrosis Foundation Therapeutics Inc [Member] | ||||||
Amount received on milestone payment | $ 1,000,000 | $ 1,250,000 | $ 1,500,000 | |||
Securities Purchase Agreement [Member] | Investors [Member] | ||||||
Aggregate common stock sold, shares | 5,960,000 | |||||
Shares issued price per share | $ 2.50 | |||||
Gross proceeds from sale of stock | $ 14,875,000 |
X | ||||||||||
- Definition Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition The cash inflow from the additional capital contribution to the entity. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition The cumulative amount of the reporting entity's undistributed earnings or deficit. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition The amount of consideration recognized during the period for the milestone or milestones. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition Per share or per unit amount of equity securities issued. No definition available.
|
X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|